39.91 USD
+0.41 (+1.04%)
39.91 USD
0 (0%)
Taking everything into account, AZTA scores 4 out of 10 in our fundamental rating. AZTA was compared to 57 industry peers in the Life Sciences Tools & Services industry. AZTA has a great financial health rating, but its profitability evaluates not so good. AZTA is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- AZTA had positive earnings in the past year.
- AZTA had a positive operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: AZTA reported negative net income in multiple years.
- AZTA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -2.71%, AZTA is in line with its industry, outperforming 54.39% of the companies in the same industry.
- The Return On Equity of AZTA (-3.23%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.71% | ||
| ROE | -3.23% | ||
| ROIC | N/A |
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With a Gross Margin value of 45.52%, AZTA perfoms like the industry average, outperforming 43.86% of the companies in the same industry.
- AZTA's Gross Margin has been stable in the last couple of years.
- AZTA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 45.52% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
2. Health
2.1 Basic Checks
- AZTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, AZTA has more shares outstanding
- The number of shares outstanding for AZTA has been reduced compared to 5 years ago.
- AZTA has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 4.79 indicates that AZTA is not in any danger for bankruptcy at the moment.
- AZTA has a Altman-Z score of 4.79. This is in the better half of the industry: AZTA outperforms 77.19% of its industry peers.
- The Debt to FCF ratio of AZTA is 0.04, which is an excellent value as it means it would take AZTA, only 0.04 years of fcf income to pay off all of its debts.
- With an excellent Debt to FCF ratio value of 0.04, AZTA belongs to the best of the industry, outperforming 92.98% of the companies in the same industry.
- AZTA has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
- AZTA's Debt to Equity ratio of 0.00 is fine compared to the rest of the industry. AZTA outperforms 75.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.04 | ||
| Altman-Z | 4.79 |
ROIC/WACCN/A
WACC10.94%
2.3 Liquidity
- A Current Ratio of 2.98 indicates that AZTA has no problem at all paying its short term obligations.
- AZTA has a Current ratio (2.98) which is comparable to the rest of the industry.
- AZTA has a Quick Ratio of 2.66. This indicates that AZTA is financially healthy and has no problem in meeting its short term obligations.
- AZTA's Quick ratio of 2.66 is in line compared to the rest of the industry. AZTA outperforms 56.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.98 | ||
| Quick Ratio | 2.66 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 29.27% over the past year.
- AZTA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.04% yearly.
- The Revenue has decreased by -9.52% in the past year.
- Measured over the past years, AZTA shows a quite strong growth in Revenue. The Revenue has been growing by 8.86% on average per year.
EPS 1Y (TTM)29.27%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%16.67%
Revenue 1Y (TTM)-9.52%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%-6.39%
3.2 Future
- The Earnings Per Share is expected to grow by 27.49% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 5.37% on average over the next years.
EPS Next Y50.72%
EPS Next 2Y39.62%
EPS Next 3Y34.08%
EPS Next 5Y27.49%
Revenue Next Year4.54%
Revenue Next 2Y4.91%
Revenue Next 3Y5.21%
Revenue Next 5Y5.37%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 75.30, the valuation of AZTA can be described as expensive.
- AZTA's Price/Earnings is on the same level as the industry average.
- Compared to an average S&P500 Price/Earnings ratio of 27.54, AZTA is valued quite expensively.
- A Price/Forward Earnings ratio of 49.96 indicates a quite expensive valuation of AZTA.
- AZTA's Price/Forward Earnings ratio is in line with the industry average.
- When comparing the Price/Forward Earnings ratio of AZTA to the average of the S&P500 Index (24.31), we can say AZTA is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 75.3 | ||
| Fwd PE | 49.96 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AZTA is on the same level as its industry peers.
- 64.91% of the companies in the same industry are more expensive than AZTA, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 47.76 | ||
| EV/EBITDA | 36.16 |
4.3 Compensation for Growth
- AZTA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- A more expensive valuation may be justified as AZTA's earnings are expected to grow with 34.08% in the coming years.
PEG (NY)1.48
PEG (5Y)N/A
EPS Next 2Y39.62%
EPS Next 3Y34.08%
5. Dividend
5.1 Amount
- No dividends for AZTA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
39.91
+0.41 (+1.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-21 2025-11-21/bmo
Earnings (Next)02-03 2026-02-03/amc
Inst Owners111.91%
Inst Owner ChangeN/A
Ins Owners0.63%
Ins Owner Change11.23%
Market Cap1.83B
Revenue(TTM)593.82M
Net Income(TTM)-55.76M
Analysts75.71
Price Target39.63 (-0.7%)
Short Float %9.1%
Short Ratio6.22
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.43%
Min EPS beat(2)8.65%
Max EPS beat(2)36.22%
EPS beat(4)3
Avg EPS beat(4)13.04%
Min EPS beat(4)-29.97%
Max EPS beat(4)37.26%
EPS beat(8)7
Avg EPS beat(8)70.99%
EPS beat(12)10
Avg EPS beat(12)146.49%
EPS beat(16)14
Avg EPS beat(16)123.62%
Revenue beat(2)0
Avg Revenue beat(2)-2.8%
Min Revenue beat(2)-5.56%
Max Revenue beat(2)-0.05%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-5.56%
Max Revenue beat(4)-0.05%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)4
Avg Revenue beat(12)-1.11%
Revenue beat(16)7
Avg Revenue beat(16)-0.95%
PT rev (1m)0.74%
PT rev (3m)23.64%
EPS NQ rev (1m)-0.52%
EPS NQ rev (3m)-18.85%
EPS NY rev (1m)-0.15%
EPS NY rev (3m)1.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.31%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 75.3 | ||
| Fwd PE | 49.96 | ||
| P/S | 3.08 | ||
| P/FCF | 47.76 | ||
| P/OCF | 25.36 | ||
| P/B | 1.06 | ||
| P/tB | 1.98 | ||
| EV/EBITDA | 36.16 |
EPS(TTM)0.53
EY1.33%
EPS(NY)0.8
Fwd EY2%
FCF(TTM)0.84
FCFY2.09%
OCF(TTM)1.57
OCFY3.94%
SpS12.95
BVpS37.66
TBVpS20.12
PEG (NY)1.48
PEG (5Y)N/A
Graham Number21.19
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.71% | ||
| ROE | -3.23% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 45.52% | ||
| FCFM | 6.45% |
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.29
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.04 | ||
| Debt/EBITDA | 0.02 | ||
| Cap/Depr | 55.31% | ||
| Cap/Sales | 5.7% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 182.57% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.98 | ||
| Quick Ratio | 2.66 | ||
| Altman-Z | 4.79 |
F-Score5
WACC10.94%
ROIC/WACCN/A
Cap/Depr(3y)47.53%
Cap/Depr(5y)73.52%
Cap/Sales(3y)6.46%
Cap/Sales(5y)8.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.27%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%16.67%
EPS Next Y50.72%
EPS Next 2Y39.62%
EPS Next 3Y34.08%
EPS Next 5Y27.49%
Revenue 1Y (TTM)-9.52%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%-6.39%
Revenue Next Year4.54%
Revenue Next 2Y4.91%
Revenue Next 3Y5.21%
Revenue Next 5Y5.37%
EBIT growth 1Y70.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year516.37%
EBIT Next 3Y105.29%
EBIT Next 5YN/A
FCF growth 1Y210.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y45.11%
OCF growth 3YN/A
OCF growth 5Y13.75%
AZENTA INC / AZTA FAQ
Can you provide the ChartMill fundamental rating for AZENTA INC?
ChartMill assigns a fundamental rating of 4 / 10 to AZTA.
What is the valuation status of AZENTA INC (AZTA) stock?
ChartMill assigns a valuation rating of 3 / 10 to AZENTA INC (AZTA). This can be considered as Overvalued.
How profitable is AZENTA INC (AZTA) stock?
AZENTA INC (AZTA) has a profitability rating of 2 / 10.
Can you provide the financial health for AZTA stock?
The financial health rating of AZENTA INC (AZTA) is 7 / 10.
How sustainable is the dividend of AZENTA INC (AZTA) stock?
The dividend rating of AZENTA INC (AZTA) is 0 / 10 and the dividend payout ratio is 0%.